A Long-Term Extension Trial From Late Phase II of SPM 962 in Patients With Restless Legs Syndrome

Clinical trial NCT01562743 · COMPLETED

Trial details

NCT number: NCT01562743
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Idiopathic Restless Legs Syndrome

Start date: 2008-08-01
Primary completion: 2010-10-01
Enrollment: 185

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.